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Abstract
The fibroblast growth factor receptor (FGFR) can be activated through direct interaction with the neural
cell adhesion molecule (NCAM). The extracellular part of the FGFR consists of three immunoglobulin-
like (Ig) modules, and that of the NCAM consists of five Ig and two fibronectin type III (F3) modules.
NCAM–FGFR interactions are mediated by the third FGFR Ig module and the second NCAM F3
module. Using surface plasmon resonance and nuclear magnetic resonance analyses, the present study
demonstrates that the second Ig module of FGFR also is involved in binding to the NCAM. The second
Ig module residues involved in binding were identified and shown to be localized on the ‘‘opposite
sides’’ of the module, indicating that when NCAMs are clustered (e.g., due to homophilic binding),
high-affinity FGFR binding sites may be formed by the neighboring NCAMs.
Keywords: FGF receptor; NCAM; F3 module; NMR spectroscopy; surface plasmon resonance spectroscopy
The fibroblast growth factor (FGF) receptors (FGFR) 1
through 4 can be activated by their cognate ligands, the
FGFs (Mc Keehan et al. 1998; Itoh and Ornitz 2004), and
by cell adhesion molecules (CAMs) such as the neural cell
adhesion molecule (NCAM), L1-CAM, and N-cadherin
(Doherty and Walsh 1996; Kiselyov et al. 2003). Whereas
the basic principles of FGFR activation by FGFs are well
understood (Plotnikov et al. 1999; Pellegrini et al. 2000),
the mechanism of FGFR activation by CAMs is not clear.
In the absence of FGF, FGFR exists in the cell membrane as
a monomeric protein that dimerizes upon binding to FGF.
FGFR dimerization brings the tyrosine kinase domains of
two receptor molecules into close proximity to each other,
followed by autophosphorylation of the kinase domains, and
thus receptor activation. In contrast to transiently expressed
FGFs, CAMs are expressed constitutatively, and are thought
to activate FGFR only when they are involved in cell–cell
adhesion (Kiselyov et al. 2005).
The NCAM is a cell-surface glycoprotein belonging to
the Ig superfamily (Berezin et al. 2000; Kiselyov et al.
2005). The NCAM can be expressed as three major isoforms
(A, B, and C), with differences in the cytoplasmic domain.
The extracellular region of the NCAM is identical for the
three isoforms, and consists of five Ig-like and two fibro-
nectin type III (F3) modules. The NCAM plays a major role
during nervous system development, mediating adhesion
between neural cells, stimulating neurite outgrowth and
fasciculation, and promoting cell survival and synaptic
plasticity (Cremer et al. 1997; Berezin et al. 2000; Bruses
and Rutishauser 2001; Rougon and Hobert 2003; Walmod
et al. 2004). The NCAMmediates cell–cell adhesion through
homophilic binding and regulates neurite outgrowth via
FGFR (Doherty and Walsh 1996; Kiselyov et al. 2003).
The mechanism of the NCAM homophilic binding,
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although extensively studied, is still controversial (for a
thorough review of the available structural data, see
Kiselyov et al. 2005). The Ig1 and Ig2 modules of the
NCAM were demonstrated to bind to each other, which
indicates that these modules are involved in a symmetrical
double-reciprocal interaction (Kiselyov et al. 1997; Atkins
et al. 1999; Jensen et al. 1999; Kasper et al. 2000).
Recently, the crystal structure of the first three N-terminal
NCAM modules has been determined (Soroka et al. 2003),
and based on this structure, a model of the NCAM
homophilic binding has been suggested. According to this
model, interactions between the Ig1 and Ig2 modules lead
to formation of the NCAM cis-dimers on the surface of the
same cell. The cis-dimers from two opposing cells can form
two kinds of one-dimensional ‘‘zippers.’’ When combined,
the two types of ‘‘zippers’’ may form a two-dimensional
‘‘zipper.’’
The extracellular region of the prototypical FGFR
consists of three Ig modules of the intermediate subtype
(Plotnikov et al. 1999; Pellegrini et al. 2000; Kiselyov
et al. 2006a). The Ig2 and Ig3 modules mediate binding to
FGF and heparin, whereas the Ig1 module has an auto-
inhibitory function (Wang et al. 1995; Olsen et al. 2004)
through direct binding to Ig2 (Kiselyov et al. 2006b). The
FGFR site involved in binding to the NCAM has been
mapped to the Ig3 module, and the corresponding NCAM
site to the F3(2) module (Kiselyov et al. 2003). Affinity
of interaction between the FGFR Ig2–3 modules and the
F3(1–2) modules of the NCAM is much higher than
affinity of interaction between the single Ig3 and the
F3(2) module. Therefore, it seems likely that Ig2 and the
F3(1) module also are involved in this interaction. Thus,
it is of interest to test whether the FGFR Ig2 module is
involved in the FGFR–NCAM interaction.
Results
To study the possible binding between the FGFR Ig2
module and the NCAM, recombinant proteins of the
NCAM F3(1–2) modules and the FGFR Ig2 module
expressed in a yeast expression system of Pichia pastoris
were used. Both proteins were properly folded as judged
by one-dimensional NMR.
The FGFR Ig2 module binds to the NCAM
It has previously been shown by SPR that the double-
module construct of the F3(1–2) modules of the NCAM
binds to the double Ig2–3 FGFR module construct with
a dissociation constant (Kd) of 10 mM (Kiselyov et al.
2003). However, interactions between the individual
modules were minimally detected by SPR, indicating that
both NCAM modules as well as both FGFR modules are
involved in binding or are necessary for maximal binding.
By using a method more sensitive to weak binding, NMR,
an interaction between the F3(2) module of the NCAM
and the FGFR Ig3 module was detected (Kiselyov et al.
2003). The binding site in the F3(2) module of the NCAM
was mapped to the FG-loop region of the module, which
is located in the N-terminal part of the module (Kiselyov
et al. 2003). This indicates that the C-terminal part of the
F3(1) module of the NCAM, together with the N-terminal
part of the F3(2) module, might form a single binding site
for FGFR, and this site may be destroyed when the
modules are separated. Binding of the FGFR Ig2 module
to the F3(1–2) modules of the NCAM was therefore
tested. Using SPR, binding of the soluble FGFR Ig2
module to the immobilized F3(1–2) modules of the
NCAM was detected (Fig. 1A). The Kd value for this
interaction was estimated to be 34.3 6 1.4 mM by fitting
the plot of the maximum binding versus ligand concen-
tration with the theoretical curve (Fig. 1B). When the
FGFR Ig2 module was immobilized, binding of the
soluble F3(1–2) modules of the NCAM to the immobi-
lized Ig2 module could also be demonstrated (Fig. 1C).
The Kd value for this binding was estimated to be 45.5 6
9.2 mM by fitting the plot of the maximum binding versus
ligand concentration with the theoretical curve (Fig. 1D).
These data indicate that the Ig2 FGFR module is also
involved in binding to the NCAM F3 modules.
Mapping of the FGFR Ig2 module residues involved
in binding to the NCAM
Since the FGFR Ig2 module binds to the F3(1–2) modules
of the NCAM, it was of interest to identify the residues of
the Ig2 module in the vicinity of the binding site using
NMR spectroscopy. The 15N-heteronuclear single quan-
tum correlation (HSQC) spectrum of a 15N-labeled protein
records the one-bond coupling of an H–N bond, and is
therefore a useful tool for monitoring site-specific pertur-
bations. The assignment of the 15N-HSQC spectrum of a
15N-labeled Ig2 FGFR module has been reported recently
(Kiselyov et al. 2006b). The chemical shift changes of the
signals provide a means to identify the amino acid residues
whose NMR signals are perturbed by the binding of another
molecule. 15N-HSQC spectra of a 40 mM Ig2 module was
recorded in the presence of 0, 13, 25, or 40 mM F3(1–2)
modules of NCAM. Addition of F3(1–2) modules of the
NCAM led to either line-broadening, chemical shift
changes or, for certain residues, disappearance of the NMR
signals. The residues with NMR signal undergoing sig-
nificant chemical shift changes, >0.03 ppm for the 13 mM
F3(1–2) modules and 0.05 ppm for the 25 and 40 mM
F3(1–2) modules, or disappearing completely, were con-
sidered to be specifically perturbed by the binding. The
recorded changes of chemical shifts and mapping of the
significantly perturbed residues onto the structure of the Ig2
FGFR activation by NCAM
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module (Plotnikov et al. 1999) are shown in Figure 2. As
can be seen from Figure 2C, addition of 40 mM F3(1–2)
modules perturbed most of the Ig2 module’s residues, and
most of the signals disappeared. This indicates that the
exchange between the bound and unbound form of the Ig2
module is intermediate on the NMR timescale. Since
addition of 13 mM F3(1–2) modules led to perturbation
of only a few residues (Fig. 2A), 40 mM F3(1–2) modules
perturbed most of the residues (Fig. 2C), whereas 25 mM
F3(1–2) modules perturbed 23 residues (Fig. 2B), the latter
were decided to represent the residues of the Ig2 module
perturbed by the F3(1–2) modules of the NCAM. As can
be seen from Figure 2B, the perturbed residues appear to
consist of two clusters. The first cluster involves residues
T156, S157, E159, A171, T173, V174, K175, S181, S214, M217,
D218, S219, and V220, while the second cluster involves
residues M161, L191, K192, N193, F197, V221, T229, C230, D246,
and V248. Perturbation of these residues shows that the
presence of the NCAM F3(1–2) modules close to the FGFR
Ig2 module alters the chemical environment at the per-
turbed residues, indicating that the perturbed residues are
either a part of, or in the vicinity of, the binding site for the
interaction between the NCAM and FGFR.
Validation of the binding sites in the FGFR Ig2 module
identified by NMR
The first cluster is located in close proximity to the
binding sites for FGF, heparin, and Ig2 itself (Fig. 3;
Plotnikov et al. 1999; Pellegrini et al. 2000). From Figure
3, it appears that heparin may inhibit the binding of the
FGFR Ig2 module to NCAM. To test this assumption,
the ability of sucrose octasulphate (SOS), a well-known
heparin analog, to inhibit binding of the soluble Ig2
module to the immobilized F3(1–2) modules of NCAM
was investigated. As shown in Figure 4, SOS was indeed
capable of inhibiting the Ig2–NCAM binding, as expected
based on the fact that the first cluster is located close to
the heparin-binding site of the FGFR Ig2 module. Since
there is no suitable ligand binding to the FGFR Ig2
Figure 1. Surface plasmon resonance analysis of the binding between the FGFR Ig2 module and the NCAM F3 modules. (A) Binding
of the soluble FGFR Ig2 module to the immobilized NCAM F3 modules (with a fitting of the saturation plot shown in B). (C) Binding
of the soluble NCAM F3 modules to the immobilized FGFR Ig2 module (with a fitting of the saturation plot shown in D). The
experiment was repeated nine times.
Kochoyan et al.
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module in the vicinity of the second cluster, we attempted
to demonstrate the presence of the second binding site in
the FGFR Ig2 module for the NCAM by analysis of a
binding isotherm (measured by SPR) of the NCAM F3(1–
2) modules (using a concentration range from 1 to 500
mM) to the immobilized Ig2 module. It should be noted
that this method can demonstrate the presence of two
binding sites only if their Kd values differ by >100-fold.
The recorded binding isotherm failed to show the pres-
ence of the second site (data not shown), which could be
due to the fact that the Kd values of the two sites are
approximately the same (or not sufficiently different).
However, analysis of the competition isotherm, in which
the binding level of Ig2 (from Fig. 4) versus SOS
concentration is shown on a logarithmic scale (see Fig.
5A), reveals the presence of the second site. One can
clearly see that the competition isotherm is not mono-
phasic, and fitting of the data with a single site model pro-
duces a very bad fit (see Fig. 5A). Fitting of the data with a
two-site model produces an excellent fit (see Fig. 5B)
Figure 2. Mapping of the FGFR Ig2 module’s residues involved in the NCAM binding. Changes in chemical shifts of the 10 mM 15N-
labeled Ig2 module after addition of (A) 13 mM, (B) 25 mM, and (C) 40 mM unlabeled NCAM F3 modules and mapping of the
significantly perturbed residues onto the FGFR Ig2 module structure (right panels). The crystal structure of human FGFR Ig2 module
(PDB code: 1EVT) was used for mapping. MolMol software version 2K.2 was used for creating graphical representations of molecular
structures. Origin software version 6.1 was used to create diagrams.
FGFR activation by NCAM
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in which SOS inhibits 67 6 2% of the Ig2 binding with a
Kd of 7.5 6 1.4 mM and 33 6 2% of the binding with a Kd
of 1.9 6 0.4 mM. Since the Kd of the heparin–FGFR
binding is in the mM range, it is reasonable to assume that
the 7.5 mM Kd corresponds to an interaction of SOS with
the heparin-binding site of Ig2, and thus 67% of the Ig2
binding occurs via the first site identified by NMR (which
is in the vicinity of the heparin-binding site). The remaining
33% of the binding occurs via a different site. This
interaction can also be inhibited by SOS (binding, probably
unspecifically, either to the FGFR or NCAM), but affinity
of the SOS binding to this site is extremely low (1.9 mM
Kd). The fact that there is only a twofold difference between
the binding levels of the two sites (67% and 33% of the
total binding) indicates that affinities for the two sites are
similar. Another way of demonstrating the presence of two
binding sites is to estimate the Kd values for the two sites
from the concentration dependence of the chemical shifts
changes. Unfortunately, this method is not applicable in our
case due to the intermediate exchange (see above) between
the bound and unbound forms of the protein.
Discussion
The present study demonstrates for the first time that the
FGFR Ig2 module is involved in direct binding to the
F3(1–2) modules of the NCAM. The binding affinity for
the Ig2 module and the F3(1–2) modules (Kd value of
;34–46 mM) was three to four times lower than affinity
for the double-module constructs of the FGFR Ig2–3
modules and the F3(1–2) modules of the NCAM (Kd
value of ;10 mM), which may be expected because the
Ig3 module is also involved in this binding (Kiselyov
et al. 2003). Since the Ig3 module is known to bind to the
F3(2) module of the NCAM (Kiselyov et al. 2003), the
Ig2 module is expected to bind to the F3(1) module.
Surprisingly, the Ig2 module was found by NMR to have
two possible binding sites for the NCAM, which are
located on the ‘‘opposite sides’’ of the module. It should
be noted that it is not possible to distinguish by NMR
whether an identified site corresponds to a real binding
event or the perturbation occurs due to slight structural
changes in the module caused by binding at another site.
Fortunately, one of the identified sites is located in the
vicinity of the Ig2 module’s site for heparin, and the pres-
ence of this site was confirmed by inhibition of the Ig2–
NCAM binding by a heparin analog, SOS. Analysis of the
binding isotherm has not given any information about
whether or not the second site corresponds to a real binding
event. However, analysis of the competition isotherm (by
Figure 3. Mapping of the various FGFR Ig2 module’s binding sites onto the module’s structure. For the NCAM binding site, the first
and second clusters are shown in magenta and aquamarine, respectively. The crystal structure of the human FGFR Ig2 module (PDB
code: 1EVT) was used for mapping. MolMol software version 2K.2 was used for creating graphical representations of molecular
structures.
Figure 4. Surface plasmon resonance analysis of the inhibitory effect of
sucrose octasulphate (SOS) on binding of the FGFR Ig2 module to the
NCAM F3 modules. The experimental setup was the same as described in
Figure 1. The binding of 20 mM FGFR Ig2 module to the immobilized
NCAM F3 modules was studied in the presence of the indicated
concentrations of SOS. The experiment was repeated nine times.
Kochoyan et al.
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SOS) reveals the presence of two sites in the FGFR Ig2
module with similar affinities for the NCAM (which is
probably the reason why the two sites are indistinguishable
in the binding isotherm), but very different affinities for
SOS. The fact that SOS can inhibit the two sites with binding
constants differing by almost 300-fold makes the two sites
easily identifiable in the competition isotherm. SOS inhibits
one of the sites with 7.5 mM Kd (which corresponds to
binding of SOS to the heparin binding site of FGFR) and
another one, with 1.9 mM Kd. The latter interaction (either
with the NCAM or FGFR) is probably unspecific, and is
very unlikely to have any physiological relevance, but it
turned out to be quite useful in showing the presence of the
second site. It should be noted that one cannot be certain
that this site corresponds to the second cluster of perturbed
residues identified by NMR. However, the fact that the
competition isotherm clearly demonstrates the presence of
two binding sites in the FGFR Ig2 module makes it quite
plausible that the two clusters of perturbed residues
(identified by NMR) correspond to real binding events.
The mechanism of the FGFR activation by the NCAM
is not well understood. It has been hypothesized that most
FGFR molecules are involved in a transient interaction
with the NCAM (Kiselyov et al. 2003, 2005), and when
the NCAM is not involved in cell–cell adhesion, the
NCAMs are uniformly spread on the cell surface. How-
ever, when the NCAM is involved in cell–cell adhesion
(via homophilic binding), NCAMs may arrange them-
selves into the so-called ‘‘zipper’’ formations (Soroka
et al. 2003), presumably leading to clustering of the
NCAMs, and as a result, to subsequent clustering of the
FGFR molecules. The increase in local concentration of
the FGFR molecules may be expected to increase the
number of the FGFR molecules involved in the direct
FGFR–FGFR binding, which could result in the FGFR
activation (Kiselyov et al. 2005).
The possible FGFR binding simultaneously to two
NCAMs, found in this study, permits modification of the
aforementioned model of the FGFR activation by the NCAM.
We hypothesize that in the absence of the NCAM-mediated
cell–cell adhesion (i.e., when the NCAM is not involved in
trans-homophilic binding), the FGFR molecules do not
bind substantially to the NCAM (see Fig. 6A). However,
when the NCAM is involved in trans-homophilic binding,
the NCAMs become clustered due to formation of ‘‘zip-
per’’-like structures (Soroka et al. 2003), thus allowing an
FGFR molecule to bind simultaneously to two neighboring
NCAMs with a much higher affinity than to individual
NCAMs, ensuring an efficient NCAM–FGFR interaction
(Fig. 6B). Thus, FGFR is expected to bind to, and become
activated by, NCAMs only when the NCAM is clustered
through a trans-homophilic binding mechanism. It should
be noted that FGFR may also be bound to the neighboring
NCAMs belonging to the same NCAM cis-dimer, as shown
in Figure 6C, which appears to be nonphysiological, since it
would lead to a constitutatively strong interaction between
the NCAM and FGFR regardless of whether the NCAM is
involved in the trans-homophilic binding or not. However,
this model cannot be excluded based on our data alone.
Thus, we have demonstrated for the first time a direct
binding between the FGFR Ig2 module and the NCAM.
The Ig2 module turned out to have two putative binding
sites for the NCAM, which allowed us to formulate a
speculative model for the molecular mechanism of the
NCAM interaction with the FGFR. Whether or not the
model is true requires further investigation.
Materials and Methods
Production of recombinant proteins
The mouse FGFR1 Ig2 module (3c isoform) and the rat double-
module construct of the F3(1–2) modules of the NCAM were
produced as previously described (Kiselyov et al. 2003, 2006b).
Figure 5. Competition isotherm (by SOS) of the FGFR Ig2 module bind-
ing to the NCAM. The isotherm shows the maximum binding level of Ig2
at 20 mM concentration versus SOS concentration. The data were fitted with
a single site model in A and a two-site model in B. The data are shown as
averagesof six replicates,with error bars corresponding to standarddeviations.
FGFR activation by NCAM
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Surface plasmon resonance analysis
The binding experiments were performed at 25°C using a CM5
sensor chip. Proteins were immobilized on the chip surface by
amine coupling. PBS (pH 7.40) was used as running buffer.
Immobilization and binding analysis were performed using a
BIAcore2000 instrument (Biosensor Applications AB) as pre-
viously described (Kiselyov et al. 2003). The Kd values were
determined by fitting the saturation data to the theoretical
binding curve.
NMR measurements
The following samples were used for recording of NMR spectra:
40 mM 15N-FGFR Ig2 module with or without 13, 25, and
40 mM F3 modules of the NCAM. The buffer was 10 mM
sodium phosphate containing 150 mM NaCl, pH 7.4. The
samples were analyzed by recording 15N-HSQC spectra using
the standard setup provided by ProteinPack. The spectra were
processed by NMRPipe (Delaglio et al. 1995) and analyzed by
Pronto3D (Kjaer et al. 1994). Changes of chemical shifts were
calculated as [(5  DH)2+ DN2]0.5, where DH is the change of the
1H chemical shift, and DN is the change of the 15N chemical shift.
The NMR experiments were performed using Varian Unity Inova
750 and 800 MHz spectrometers. All spectra were recorded at
25°C.
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